Xofluza

Xofluza Indications/Uses

baloxavir marboxil

Manufacturer:

Roche

Distributor:

Zuellig Pharma
Full Prescribing Info
Indications/Uses
Treatment of Influenza: XOFLUZA is indicated for the treatment of acute uncomplicated influenza in patients 12 years of age and older who have been symptomatic for no more than 48 hours and who are: otherwise healthy, or at high risk of developing influenza-related complications [see Pharmacology: Clinical Studies: Treatment of Acute Uncomplicated Influenza - High Risk Subjects under Actions].
Post-Exposure Prophylaxis of Influenza: XOFLUZA is indicated for post-exposure prophylaxis of influenza in persons 12 years of age and older following contact with an individual who has influenza [see Pharmacology: Clinical Studies: Post-Exposure Prophylaxis of Influenza under Actions].
Limitations of Use: Influenza viruses change over time, and factors such as the virus type or subtype, emergence of resistance, or changes in viral virulence could diminish the clinical benefit of antiviral drugs. Consider available information on drug susceptibility patterns for circulating influenza virus strains when deciding whether to use XOFLUZA [see Microbiology and Pharmacology: Clinical Studies under Actions].
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Already a member? Sign in
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Already a member? Sign in